Crosstalk between 5-methylcytosine and N-methyladenosine machinery defines disease progression, therapeutic response and pharmacogenomic landscape in hepatocellular carcinoma.

Mol Cancer

Department of General Surgery and Integrated Chinese and Western Medicine, Institute of Precision Diagnosis and Treatment of Digestive System Tumors, Carson International Cancer Center, Shenzhen University General Hospital, Shenzhen University, Shenzhen, Guangdong, 518055, China.

Published: January 2023

Background: Accumulated evidence highlights the significance of the crosstalk between epigenetic and epitranscriptomic mechanisms, notably 5-methylcytosine (5mC) and N-methyladenosine (mA). Herein, we conducted a widespread analysis regarding the crosstalk between 5mC and mA regulators in hepatocellular carcinoma (HCC).

Methods: Pan-cancer genomic analysis of the crosstalk between 5mC and mA regulators was presented at transcriptomic, genomic, epigenetic, and other multi-omics levels. Hub 5mC and mA regulators were summarized to define an epigenetic and epitranscriptomic module eigengene (EME), which reflected both the pre- and post-transcriptional modifications.

Results: 5mC and mA regulators interacted with one another at the multi-omic levels across pan-cancer, including HCC. The EME scoring system enabled to greatly optimize risk stratification and accurately predict HCC patients' clinical outcomes and progression. Additionally, the EME accurately predicted the responses to mainstream therapies (TACE and sorafenib) and immunotherapy as well as hyper-progression. In vitro, 5mC and mA regulators cooperatively weakened apoptosis and facilitated proliferation, DNA damage repair, G2/M arrest, migration, invasion and epithelial-to-mesenchymal transition (EMT) in HCC cells. The EME scoring system was remarkably linked to potential extrinsic and intrinsic immune escape mechanisms, and the high EME might contribute to a reduced copy number gain/loss frequency. Finally, we determined potential therapeutic compounds and druggable targets (TUBB1 and P2RY4) for HCC patients with high EME.

Conclusions: Our findings suggest that HCC may result from a unique synergistic combination of 5mC-epigenetic mechanism mixed with mA-epitranscriptomic mechanism, and their crosstalk defines therapeutic response and pharmacogenomic landscape.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830866PMC
http://dx.doi.org/10.1186/s12943-022-01706-6DOI Listing

Publication Analysis

Top Keywords

5mc regulators
20
therapeutic response
8
response pharmacogenomic
8
pharmacogenomic landscape
8
hepatocellular carcinoma
8
epigenetic epitranscriptomic
8
analysis crosstalk
8
crosstalk 5mc
8
eme scoring
8
scoring system
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!